by Don Cross | Sep 16, 2020 | News, Uncategorized
Thursday September 24th @ 6:30 p.m. Roanoke Valley MS Support Group Meeting With Special Guest Speaker: Sarah Champion from Blue Ridge Associates in Neurology “Please submit all question prior to meeting for Sarah by sending them to msav4hope@gmail.com” MS...
by Don Cross | Sep 11, 2020 | News, Uncategorized
The MSAV depends on the generous support of people like you to continue its mission. To participate in one of our fundraising events online or to shop online with a small portion of your purchase going to support the MSAV, click one of the links below: Kroger Did you...
by Don Cross | Sep 11, 2020 | News, Uncategorized
We are so excited we would love to make a MS Alliance of Virginia COOKBOOK & do a fun fundraiser with them.. How cool would that be? If you have a great recipe, canning idea or craft for that matter that you would love to share please send them to Sharon Cross...
by Don Cross | Sep 11, 2020 | News, Uncategorized
A long-approved MS therapy is among the newest options being evaluated for treatment of COVID-19. The National Institute of Allergy and Infectious Diseases, the branch of the National Institutes of Health (NIH) led by Anthony S. Fauci, MD, announced in early August...
by Don Cross | Sep 6, 2020 | News, Uncategorized
A new study found that a chemical compound found in the shell of the cashew nut promotes the repair of myelin in laboratory experiments. Previous work by Vanderbilt University Medical Center researchers showed a protein called interleukin 33, or IL-33, induced myelin...
by Don Cross | Aug 25, 2020 | News, Uncategorized
The first self-administered, targeted B-cell treatment for relapsing multiple sclerosis (MS) received FDA approval on Thursday, Novartis announced. Ofatumumab (Kesimpta), an antibody targeting CD20-positive B cells, is approved for adult patients with clinically...
